GSK to seek FDA approval for Jemperli in high-profile cancer use
In what GSK says represents a potential way to transform treatment for patients with certain types of rectal…
FDA approves Reckitt’s new Mucinex cold, flu medicine
Reckitt has received approval from the U.S. Food and Drug Administration for a long-lasting cold and flu symptom-relief…
AstraZeneca, Bristol Myers Squibb Explore US$400 Billion Merger
AstraZeneca and Bristol Myers Squibb have engaged in preliminary merger talks that could create a pharmaceutical company valued…
GSK Lands Its First Lung Cancer Drug Days After Nuvalent Deal Closes — BigGo Finance
GSK had never won FDA approval for a lung cancer drug — not in decades of trying. Then,…
GSK Lands FDA Approval for Nuvalent-Acquired Jideytro for NSCLC
GSK plc GSK announced that the FDA has approved Jideytro (zidesamtinib) for previously treated ROS1-positive non-small cell lung…
$10B M&A Deal Pays Off With GSK’s First Lung Cancer Drug Approval
A drug included in one of the pharmaceutical industry’s largest acquisitions this year is starting to paying dividends…
GSK Eyes FDA Filing After Immunotherapy Succeeds in Key Rectal Cancer Study
GSK has results from a pivotal clinical trial showing rectal cancer patients treated with its drug avoided the…
HSBC Drops Pfizer to Hold: Seagen ADC Miss Leaves $43B Bet Without Catalyst
HSBC analyst Rajesh Kumar downgraded Pfizer Inc. (NYSE: PFE) from Buy to Hold on Monday, cutting the bank’s…
New FDA Nod Keeps Gilead Drug Competitive With AstraZeneca & Daiichi in Breast Cancer
The FDA has expanded the approval of a targeted Gilead Sciences therapy as a new first-line treatment for…
GSK’s Utebzi Wins FDA Nod for Complicated Urinary Tract Infections
GSK plc GSK and its Cambridge-based partner, Spero Therapeutics SPRO, announced that the FDA has approved tebipenem pivoxil for…
GSK’s Utebzi Wins FDA Nod for Complicated Urinary Tract Infections
GSK plc GSK and its Cambridge-based partner, Spero Therapeutics SPRO, announced that the FDA has approved tebipenem pivoxil for…
FDA Accepts AstraZeneca’s Filing for Expanded Use of Ultomiris
AstraZeneca AZN announced that the FDA has accepted a regulatory filing seeking to expand the use of its blockbuster…